These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21804229)

  • 1. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
    Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
    Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.
    Sonoke S; Ueda T; Fujiwara K; Sato Y; Takagaki K; Hirabayashi K; Ohgi T; Yano J
    Cancer Res; 2008 Nov; 68(21):8843-51. PubMed ID: 18974128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice.
    Sato A; Takagi M; Shimamoto A; Kawakami S; Hashida M
    Biomaterials; 2007 Mar; 28(7):1434-42. PubMed ID: 17141864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.
    Watanabe T; Umehara T; Yasui F; Nakagawa S; Yano J; Ohgi T; Sonoke S; Satoh K; Inoue K; Yoshiba M; Kohara M
    J Hepatol; 2007 Dec; 47(6):744-50. PubMed ID: 17822798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
    Hattori Y; Arai S; Kikuchi T; Ozaki KI; Kawano K; Yonemochi E
    J Drug Target; 2016 Apr; 24(4):309-317. PubMed ID: 26234899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
    Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
    J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel targeted liposomes deliver sirna to hepatocellular carcinoma cells in vitro.
    Dorasamy S; Narainpersad N; Singh M; Ariatti M
    Chem Biol Drug Des; 2012 Nov; 80(5):647-56. PubMed ID: 22783887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.
    Yano J; Hirabayashi K; Nakagawa S; Yamaguchi T; Nogawa M; Kashimori I; Naito H; Kitagawa H; Ishiyama K; Ohgi T; Irimura T
    Clin Cancer Res; 2004 Nov; 10(22):7721-6. PubMed ID: 15570006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
    Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
    Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
    Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
    J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
    Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
    Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
    Wang J; Ayano E; Maitani Y; Kanazawa H
    Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C; Kawakami S; Yamashita F; Hashida M
    J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and improved anticancer effect of NIK-siRNA in combination with 5-FU for hepatocellular carcinoma.
    Kang SS; Cho HA; Kim JS
    Arch Pharm Res; 2011 Jan; 34(1):79-86. PubMed ID: 21468918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.